- Phase II Data Of ADXS-HPV For Cervical Cancer Are Encouraging
- GALE Is Making Progresses In Its Three Clinical Programs
- NWBO: Great Progress Made To Advance DCVax-L And DCVax-Direct
- Immunovaccine Is On Track To Advance Clinical Programs
- ATOS: Any Retreat In Share Price Should Provide A Good Entry Opportunity
Grant Zeng
ABOUT
Grant Zeng has over 10 years of professional experience in equity research and analysis. Grant joined Zacks Investment Research Inc. in March 2006, and currently is a senior equity analyst covering biotech/pharma industry and China stocks. Before joining Zacks, Grant worked for TheStreet.com as a biotech analyst from 2005-2006. From Sept 2001 to December 2003, Grant worked for China Pacific Insurance Co. as an senior equity/fund analyst. Grant was a healthcare equity analyst with Young & Partners, LLC from Aug 2000 to September 2001. Grant had also teaching and researching experience in pharmaceutical science.
Grant Zeng obtained his MBA with a major in Finance in 2000 from McMaster University, Canada. He ...More
Grant Zeng obtained his MBA with a major in Finance in 2000 from McMaster University, Canada. He ...More
SNAPSHOT
- Description: Sell side analyst. Trading frequency: Not Trading
- Interests: Stocks - long, Stocks - short
COMPANY
Zacks Investment Research, Inc. Zacks Small-Cap Research coverage specifically looks to focus on small and micro-cap companies that are under-followed or under-valued by Wall Street. Our analysts seek to identify and report on these companies, bringing to investors a unique opportunity to gain insight on small-cap investments which are ...More
BLOG
Currently, there are no blog details for Grant Zeng.
Book
Currently, there are no book details for Grant Zeng.
Latest Comments
more »
Latest comments on Grant Zeng's Articles
LATEST ARTICLES & INSTAPOSTS
more »